This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Cipla USA Inc.
Cipla USA Inc., a subsidiary of the renowned global pharmaceutical company Cipla Limited, is headquartered in the United States and operates extensively across North America. Founded in 1935, Cipla has established itself as a leader in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of a diverse range of high-quality generic and branded medications. Cipla USA is particularly noted for its commitment to providing affordable healthcare solutions, specialising in areas such as respiratory, oncology, and anti-infective therapies. The company’s innovative approach to drug formulation and delivery sets it apart in a competitive market. With a strong emphasis on research and development, Cipla USA has achieved significant milestones, including numerous FDA approvals, solidifying its position as a trusted provider of essential medicines.
DitchCarbon Score
How does Cipla USA Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cipla USA Inc.'s score of 47 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cipla USA Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Cipla Limited, which may influence its climate commitments and performance metrics. Cipla USA Inc. inherits its climate-related data from its parent company, Cipla Limited, at a cascade level of 1. However, no specific reduction targets or initiatives have been documented for Cipla USA Inc. itself. The absence of documented reduction targets suggests that the company may be aligning its climate strategy with broader corporate initiatives set by Cipla Limited. As part of its corporate family, Cipla USA Inc. may benefit from the sustainability practices and commitments of Cipla Limited, which is actively engaged in addressing climate change. Nonetheless, without specific emissions data or reduction targets, it is challenging to assess Cipla USA Inc.'s individual impact or commitments in the context of carbon emissions and climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 236,358,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 55,013,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cipla USA Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
